Cambridge Healthtech Institute's 17th Annual

Advancing Multispecific Antibodies and Combination Therapy to the Clinic

Novel and Synergistic Combinations

18 November 2026 ALL TIMES WET (GMT/UTC)

Cambridge Healthtech Institute's Eighteenth Annual Advancing Multispecific Antibodies and Combination Therapy to the Clinic track at PEGS Europe will present an overview of multispecific antibodies in preclinical and clinical development, with a review of current formats, designs, and clinical status. This field is experiencing rapid growth fueled by a wealth of format diversity and translation into clinical success in oncology as well as indications in autoimmune and beyond.

Recommended Short Course*
Monday, 16 November, 14:00 – 17:00
SC2: Developability of Bispecific Antibodies
*Separate registration required. See short courses page for details. All short courses take place in-person only.





Failed to load agenda from https://api.speakers.healthtech.com/api/agenda/new/NAB2260903/final: The remote server returned an error: (500) Internal Server Error.

For more details on the conference, please contact:

Christina Lingham
Executive Director, Conferences and Fellow
Cambridge Healthtech Institute
Phone: (+1) 508-813-7570
Email: clingham@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com